The proportion of patients who experienced severe or confirmed ( 8 % at screening Semaglutide versus placebo as an add-on to SGLT2 inhibitor therapy (as monotherapy or in combination with a sulfonylurea derivative or metformin) Therapy with semaglutide at a dose of 1 mg once a week as an add-on to SGLT2 inhibitor therapy (as monotherapy or in combination with a sulfonylurea derivative or metformin) versus placebo once a week for 30 weeks resulted in statistically significant reductions in HbA1c (-1.5 % vs -0.1 %, respectively), FPG (-2.2 mmol/L vs
It is studied in research for its effects on increasing satellite cell proliferation, lowering cholesterol, inflammation reduction, and decrease of neuro-degeneration
Regular monitoring by a healthcare provider is important to ensure these changes are not harmful
It's not that we don't want to grow
Someone showing signs of metabolic syndrome like elevated triglycerides, increased waist circumference, high blood pressure, or insulin resistance might not need aggressive dosing
Some private weight loss clinics may prescribe Ozempic off label, where medication is prescribed outside the scope of its licence